ProfileGDS4718 / 213997_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 63% 61% 51% 55% 57% 44% 41% 58% 57% 54% 54% 56% 38% 42% 41% 59% 64% 36% 46% 42% 52% 55% 62% 58% 53% 43% 60% 43% 61% 40% 43% 41% 62% 56% 34% 37% 47% 51% 59% 45% 61% 42% 41% 38% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.3337963
GSM549102patient 115, normal, homogenized [OPG study]6.1694161
GSM549104patient 119, normal, homogenized [OPG study]5.5704851
GSM549108patient 138, normal, homogenized [OPG study]5.8136455
GSM549119patient 077, normal, homogenized [OPG study]5.9115757
GSM549133patient 032, cancer, homogenized [OPG study]5.1295444
GSM549139patient 042, cancer, homogenized [OPG study]5.0457341
GSM549099patient 107, normal, homogenized [OPG study]5.9788358
GSM549109patient 139, normal, homogenized [OPG study]5.9384457
GSM549110patient 046, normal, homogenized [OPG study]5.7683554
GSM549114patient 063, normal, homogenized [OPG study]5.6777654
GSM549122patient 082, normal, homogenized [OPG study]5.8744456
GSM549134patient 033, cancer, homogenized [OPG study]4.9000938
GSM549136patient 036, cancer, homogenized [OPG study]5.019742
GSM549140patient 044, cancer, homogenized [OPG study]5.0152141
GSM549111patient 047, normal, homogenized [OPG study]6.0934559
GSM549113patient 057, normal, homogenized [OPG study]6.3965464
GSM549132patient 031, cancer, homogenized [OPG study]4.7849436
GSM549137patient 038, cancer, homogenized [OPG study]5.2777646
GSM549142patient 047, cancer, homogenized [OPG study]5.2247142
GSM549100patient 110, normal, homogenized [OPG study]5.6119852
GSM549107patient 135, normal, homogenized [OPG study]5.8131655
GSM549115patient 068, normal, homogenized [OPG study]6.2198362
GSM549116patient 072, normal, homogenized [OPG study]5.9720658
GSM549120patient 078, normal, homogenized [OPG study]5.7050953
GSM549131patient 030, cancer, homogenized [OPG study]5.0568443
GSM549118patient 074, normal, homogenized [OPG study]6.1460160
GSM549129patient 027, cancer, homogenized [OPG study]5.159943
GSM549123patient 088, normal, homogenized [OPG study]6.2010261
GSM549124patient 006, cancer, homogenized [OPG study]5.0540
GSM549126patient 015, cancer, homogenized [OPG study]5.1216843
GSM549128patient 025, cancer, homogenized [OPG study]5.0240541
GSM549103patient 117, normal, homogenized [OPG study]6.2544562
GSM549117patient 073, normal, homogenized [OPG study]5.8031856
GSM549138patient 041, cancer, homogenized [OPG study]4.7003534
GSM549141patient 045, cancer, homogenized [OPG study]4.7955337
GSM549130patient 028, cancer, homogenized [OPG study]5.3512847
GSM549101patient 111, normal, homogenized [OPG study]5.5959351
GSM549105patient 128, normal, homogenized [OPG study]6.0879759
GSM549106patient 134, normal, homogenized [OPG study]5.2074445
GSM549112patient 048, normal, homogenized [OPG study]6.1719861
GSM549125patient 011, cancer, homogenized [OPG study]5.0868942
GSM549127patient 024, cancer, homogenized [OPG study]5.0309841
GSM549135patient 035, cancer, homogenized [OPG study]4.828738